Brief: Nanjing Leads Biolabs Says LBL-034 Granted Fast Track Designation By FDA
28/01/2026 01:15
Jan 28 (Reuters) - Nanjing Leads Biolabs 9887.HK: LBL-034 GRANTED FAST TRACK DESIGNATION BY FDA Further company coverage: 9887.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nanjing Leads Biolabs
See all newsBrief: Nanjing Leads Biolabs Says FDA Grants Fast Track Designation To LBL-024
Brief: Nanjing Leads Biolabs Posts HY Loss Attributable RMB221.9 Million
Nanjing Leads rises on clinical study progress on cancer treatment drug
Nanjing Leads Biolabs jumps on progress of tumor antibody treatment
Nanjing Leads Biolabs rises on NMPA's IND approval for colorectal cancer